CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial aims to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis study is for people with blood cancers like leukemia or lymphoma who need a stem cell transplant from an unrelated donor. It compares two ways to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. One method uses a d…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
Promising new pill may help kids with rare leukemia
Disease control Recruiting nowThis study tests a drug called asciminib in children aged 1 to 18 with a specific type of leukemia (Ph+ CML-CP). The goal is to see if the drug can reduce cancer cells to very low levels. About 50 children will take the drug daily, either as a liquid or pill. This is not a cure, …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Leukemia patients get continued access to promising drug in safety Follow-Up
Disease control Recruiting nowThis study is for people with chronic myeloid leukemia (CML) who have already been helped by the drug asciminib in a previous Novartis study. It aims to track long-term safety and side effects while allowing patients to keep taking the medication. About 347 participants will be m…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
Crushed pill study aims to help kids with blood cancer who Can't swallow tablets
Knowledge-focused Recruiting nowThis study looks at how the body processes venetoclax when the tablets are crushed and mixed into a liquid for children and young adults with blood cancers like leukemia or lymphoma. About 30 participants who already take venetoclax this way will have their blood levels measured.…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
2000 transplant patients to help shape future treatments
Knowledge-focused Recruiting nowThis study is gathering basic health and survival information from 2000 people who are getting a stem cell transplant for blood cancers or immune diseases. The goal is to build a database that doctors can use to improve care and answer future questions. No experimental treatments…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC
-
Chart review reveals how CML patients fare on standard imatinib in everyday practice
Knowledge-focused Recruiting nowThis study looks back at the medical records of up to 3000 people with chronic myelogenous leukemia (CML) who were treated with standard drugs like imatinib outside of a clinical trial. The goal is to understand how well these treatments work in real-world settings, including eff…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC